STOCK TITAN

Cronos Group Inc. Form 4 Filings

CRON NASDAQ

Every Form 4 that Cronos Group Inc. (CRON) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A Form 4 covers the transactions officers, directors and large holders report, so if you follow CRON and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full CRON filings page.

Rhea-AI Summary

Garnick Murray R reported acquisition or exercise transactions in this Form 4 filing.

Cronos Group Inc. director Murray R. Garnick reported a grant of 48,859.93 Deferred Share Units on August 6, 2026. Each unit provides a cash payment equal to the fair market value of Cronos common shares at redemption. Following this award, he holds 179,594.40 Deferred Share Units, which are mandatorily redeemed in cash after he ceases to be a director.

Rhea-AI Summary

RUDYK JAMES DANIEL reported acquisition or exercise transactions in this Form 4 filing.

Cronos Group Inc. director James Daniel Rudyk received a grant of 48,859.9300 Deferred Share Units (DSUs) on August 6, 2026. Following this award, he holds 362,742.2200 DSUs directly. Each DSU entitles him, upon redemption, to a lump-sum cash payment equal to the fair market value of a Cronos common share on the redemption date, and vested DSUs are mandatorily redeemed on the first trading day after he ceases to be a director.

Rhea-AI Summary

ADLER JASON MARC reported acquisition or exercise transactions in this Form 4 filing.

Cronos Group Inc. director Jason Marc Adler received a grant of 48,859.9300 Deferred Share Units, each linked to an equal number of common shares for valuation purposes. After this grant, he holds 362,742.2200 Deferred Share Units, which will be redeemed for a lump-sum cash payment based on the fair market value of Cronos Group common shares after he ceases to be a director.

Rhea-AI Summary

Cronos Group Inc. reported routine equity compensation activity by officer Terrence Gregory Joseph Doucet. On May 12, 2026, he exercised 10,597 restricted stock units (RSUs), receiving the same number of common shares at a stated price of $0.00 per share. To cover tax obligations, 5,199 common shares were disposed of at $3.75 per share in a tax-withholding transaction, which the data notes is priced in Canadian dollars. After these transactions, Doucet directly holds 110,588 common shares of Cronos Group. Each RSU represents a contingent right to receive one common share, and the exercised units reflect part of a 31,793 RSU grant that vests in three substantially equal annual installments beginning on the first anniversary of the May 12, 2025 grant date.

Rhea-AI Summary

Cronos Group Inc. reported that company officer Adam Wagner exercised restricted stock units into common shares. On May 12, 2026, 10,367 restricted stock units vested and converted into 10,367 common shares at no exercise price, increasing his directly held common shares to 103,987. The RSUs each represent a right to receive one Cronos common share, and this transaction reflects the first vesting installment of a 31,102-unit grant awarded on May 12, 2025, which vests in three substantially equal annual installments.

Rhea-AI Summary

Cronos Group Inc. officer Buggy Shannon reported routine equity compensation activity involving restricted stock units (RSUs). On May 12, 2026, Shannon exercised RSUs to acquire 20,622 common shares, shown as a derivative exercise/conversion at a stated price of $0.00 per share.

To cover tax obligations, 9,179 common shares were disposed of through a tax-withholding transaction at $2.75 per share, rather than through an open-market sale. After these transactions, Shannon directly held 178,322 common shares of Cronos Group Inc.

Rhea-AI Summary

Cronos Group Inc. officer Jared Matthew Kenost reported routine equity compensation activity. On May 12, 2026, he exercised 9,412 restricted stock units (RSUs) into common shares and had 3,701 common shares withheld at $2.75 per share to cover tax obligations.

Following these transactions, he directly owned 42,974 common shares. In addition, he was granted 30,000 new RSUs that were originally awarded on March 12, 2026 and vest in three substantially equal annual installments, adding to previously granted RSUs from March 12, 2025.

Rhea-AI Summary

Cronos Group Inc. executive Arye Weigensberg exercised restricted stock units into common shares in a compensation-related move. On May 10, 2026, 3,118 restricted stock units converted into 3,118 common shares at a stated price of $0.00 per share, increasing his direct common share holdings to 211,555 shares. Following the transaction, he also continued to hold 154,419 restricted stock units, each representing a contingent right to receive one common share of Cronos Group Inc.

Rhea-AI Summary

Cronos Group Inc. officer Adam Wagner reported routine equity compensation activity. On May 10, 2026, he exercised restricted stock units, converting 20,470 RSUs into the same number of common shares at no cash cost. Following these transactions, he directly owns 93,620 common shares. Footnotes explain these RSUs came from prior grants of 30,190 and 31,220 RSUs awarded in 2023 and 2024, each vesting in three substantially equal annual installments, so this filing reflects scheduled vesting rather than open‑market trading.

Rhea-AI Summary

Cronos Group Inc. officer Jared Matthew Kenost reported routine equity compensation activity. On May 10, 2026, previously granted restricted stock units vested and were exercised into 12,649 common shares. To cover tax obligations, 4,774 common shares were disposed of at $2.54 per share as tax-withholding, not as open-market sales. Following these transactions, he continues to hold a direct equity stake in Cronos common shares.

Rhea-AI Summary

Cronos Group Inc. officer Anna Shlimak exercised restricted stock units that converted into 28,429 common shares on March 19, 2026. These RSUs represent the first vesting portion of an 85,297-unit grant awarded on March 19, 2025, scheduled to vest in three substantially equal annual installments.

To cover related tax obligations, 9,767 common shares were withheld and disposed of at a price of $2.54 per share. After these compensation-related transactions, Shlimak directly holds 358,595 common shares of Cronos Group Inc., with no remaining derivative position reported in this filing.

Rhea-AI Summary

Cronos Group Inc. officer Terrence Gregory Joseph Doucet exercised 23,897 restricted stock units into an equal number of common shares. These RSUs were part of a grant of 71,691 units awarded on March 15, 2023, vesting in three substantially equal annual installments.

To cover tax obligations related to the vesting, 12,276 common shares were withheld at a price of C$3.44 per share. After these transactions, Doucet directly holds 105,190 common shares and 184,408 restricted stock units, showing this was primarily a compensation-related vesting and tax-withholding event rather than an open-market trade.

Rhea-AI Summary

Cronos Group Inc. officer Arye Weigensberg reported compensation-related equity transactions. On March 16, 2026, he received a grant of 12,245 restricted stock units (RSUs), each representing a right to receive one common share, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date.

On March 15, 2026, he exercised 24,236 RSUs into an equal number of common shares, reflecting the vesting of part of an earlier RSU grant made on March 15, 2023. Following these transactions, he directly owns 208,437 common shares and holds 157,537 RSUs. These are grants and conversions, not open-market purchases or sales.

Rhea-AI Summary

Cronos Group Inc. director and officer Michael Ryan Gorenstein exercised restricted stock units that converted into common shares as part of a prior equity award. He exercised 324,540 RSUs, each representing one common share, and received an equivalent number of common shares at a stated exercise price of $0.00 per share.

To satisfy tax obligations on this vesting event, 127,706 common shares were withheld at a value of $2.50 per share, leaving him with 13,213,017 common shares held directly after the transactions. Following the RSU exercise, his remaining restricted stock unit balance was 1,912,426 RSUs. These RSUs come from a 973,618-unit grant awarded on March 15, 2023, vesting in three annual installments.

Rhea-AI Summary

Cronos Group Inc. officer Anna Shlimak reported a routine equity compensation event involving restricted stock units (RSUs). On March 15, 2026, she exercised 45,226 RSUs into an equal number of common shares at a conversion price of $0.00 per share.

In connection with this vesting, 16,354 common shares were disposed of at $2.50 per share to cover tax obligations, a tax-withholding transaction rather than an open‑market sale. After these transactions, she directly holds 339,933 common shares. The RSUs were part of a 135,678‑unit grant awarded on March 15, 2023, scheduled to vest in three substantially equal annual installments.

Rhea-AI Summary

Cronos Group Inc.’s Chief Growth Officer Jeffrey David Jacobson exercised restricted stock units into common shares as part of his equity compensation. He converted 59,191 RSUs into 59,191 common shares at a stated price of $0.00 per share, increasing his direct common share holdings.

To cover tax obligations related to this vesting, 22,552 common shares were withheld at $2.50 per share in a tax-withholding disposition, which is not an open-market sale. After these transactions, Jacobson directly owns 484,681 common shares. The RSUs come from a 177,573-unit grant awarded on March 15, 2023, vesting in three substantially equal annual installments.

Rhea-AI Summary

Cronos Group Inc. officer Buggy Shannon exercised restricted stock units into common shares as part of equity compensation. On March 15, 2026, 20,938 RSUs were converted into 20,938 common shares at a conversion price of $0.00 per share.

To cover tax obligations on this vesting event, 9,202 common shares were withheld at $2.50 per share, which is recorded as a tax-withholding disposition rather than an open-market sale. After these transactions, Shannon directly holds 166,879 common shares of Cronos Group Inc.

The RSUs stem from a March 15, 2023 grant of 62,814 units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date. The filing shows no remaining derivative securities related to this grant.

Rhea-AI Summary

Cronos Group Inc. officer Adam Wagner reported an exercise of restricted stock units that converted into common shares. On March 12, 2026, he exercised 15,715 RSUs, each representing one common share, at a stated price of $0.00 per share, receiving 15,715 common shares.

After this RSU conversion, Wagner directly holds 73,150 common shares and 186,106 restricted stock units. The filing also notes a prior grant of 47,144 RSUs on March 12, 2025, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date, underscoring that this is part of an ongoing equity compensation program rather than an open-market purchase.

Rhea-AI Summary

Cronos Group Inc. officer Arye Weigensberg exercised restricted stock units into common shares. On March 12, 2026, he converted 26,825 RSUs into 26,825 common shares at no cash exercise price, reflecting a compensation-related event rather than an open‑market trade.

Following the transaction, he directly holds 184,201 common shares. Footnotes explain that each RSU represents a right to receive one common share and reference a prior grant of 80,474 RSUs vesting in three substantially equal annual installments beginning on the first anniversary of the March 12, 2025 grant date.

Rhea-AI Summary

Cronos Group Inc. director and officer Michael Ryan Gorenstein exercised restricted stock units into common shares and had a portion withheld for taxes. He converted 339,879 RSUs into 339,879 common shares. Of these, 132,991 common shares were withheld at $2.56 per share to cover tax obligations, a non‑market disposition.

After these transactions, he directly holds 13,016,183 common shares and no remaining derivative position from this RSU grant. The RSUs exercised are part of a larger award of 1,019,736 RSUs that vest in three substantially equal annual installments beginning on the first anniversary of the March 12, 2025 grant date.

Rhea-AI Summary

Cronos Group Inc. Chief Growth Officer Jeffrey David Jacobson exercised restricted stock units into common shares. He converted 65,179 RSUs, with each unit delivering one common share. A portion of the resulting 65,179 common shares was used to satisfy tax obligations, with 24,926 shares withheld at a price of $2.56 per share. After these compensation-related and tax-withholding transactions, Jacobson directly owned 448,042 common shares.

Rhea-AI Summary

Cronos Group Inc. executive Anna Shlimak exercised 47,368 restricted stock units (RSUs) into an equal number of common shares. The RSUs had a conversion price of $0.00 per share, reflecting a routine vesting event rather than an open‑market purchase.

To cover tax obligations related to this vesting, 17,230 common shares were withheld at a reported price of $2.56 per share, which is not an open‑market sale. After these transactions, Shlimak directly holds 311,061 common shares and 460,548 RSUs. A prior grant of 142,105 RSUs vests in three substantially equal annual installments beginning on the first anniversary of its grant date.

Rhea-AI Summary

Cronos Group Inc. officer Buggy Shannon exercised restricted stock units into common shares as part of equity compensation. On March 12, 2026, 21,930 RSUs converted into 21,930 common shares at a stated price of $0.00 per share.

To cover tax obligations from this vesting, 9,728 common shares were withheld at $2.56 per share and delivered back to the issuer. After these transactions, Shannon directly owned 155,143 common shares of Cronos Group Inc.

Rhea-AI Summary

Cronos Group Inc. reported that company officer Terrence Gregory Joseph Doucet exercised restricted stock units into common shares. On March 12, 2026, he converted 23,809 RSUs into the same number of common shares at a stated price of $0.00 per share.

To cover tax obligations related to this vesting, 12,235 common shares were withheld at a price denominated in Canadian dollars of $3.48 per share, leaving a net increase of 11,574 common shares. Following these transactions, he directly owned 93,569 common shares and 208,305 restricted stock units, with the RSUs originally granted as 71,428 units on March 12, 2025 vesting in three equal annual installments.

Rhea-AI Summary

Wagner Adam reported acquisition or exercise transactions in this Form 4 filing.

Cronos Group Inc. reported that officer Adam Wagner received a grant of restricted stock units as part of his equity compensation. On March 9, 2026, he was awarded 63,189 RSUs, each representing the right to receive one common share of Cronos Group Inc. The RSUs vest in three substantially equal annual installments beginning on the first anniversary of the grant date, meaning the award will deliver shares over a three-year period if vesting conditions are met. Following this grant, Wagner holds 201,821 restricted stock units directly, aligning his compensation more closely with the company’s share performance.

Rhea-AI Summary

Cronos Group Inc. reported that officer Terrence Gregory Joseph Doucet received and exercised equity awards rather than trading shares on the open market. On March 9, 2026, he was granted 80,555 restricted stock units (RSUs), each representing a contingent right to receive one common share, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date.

On March 8, 2026, he exercised 24,434 RSUs into the same number of common shares, then had 12,580 common shares withheld at $3.51 per share to cover tax obligations, a non–open-market disposition. Following these transactions, he directly held 81,995 common shares and 232,114 RSUs, reflecting routine compensation and vesting activity rather than discretionary buying or selling.

Rhea-AI Summary

Cronos Group Inc. reported that officer Arye Weigensberg received an equity compensation grant and exercised previously awarded units. On March 9, 2026, he was granted 63,919 restricted stock units (RSUs), each representing the right to receive one common share, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date.

On March 8, 2026, Weigensberg exercised 21,484 RSUs previously granted, acquiring the same number of common shares at a price of $0.00 per share. Following these transactions, he directly holds 157,376 common shares and 196,353 RSUs, reflecting routine compensation-related equity activity without any open-market purchases or sales.

Rhea-AI Summary

Cronos Group Inc. reported equity compensation and related share movements for Chief Growth Officer Jeffrey David Jacobson. On March 9, 2026, he received a grant of 144,561 restricted stock units (RSUs), each representing a contingent right to one common share, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date. On March 8, 2026, he exercised 60,536 RSUs into the same number of common shares, and 25,605 common shares were withheld at $2.57 per share to satisfy tax obligations. Following these transactions, he directly holds 407,789 common shares and 459,845 RSUs.

Rhea-AI Summary

Cronos Group Inc. director and officer Michael Ryan Gorenstein reported equity compensation and related share movements. On March 9, 2026, he received a grant of 904,669 restricted stock units (RSUs), each representing one common share, bringing his RSU holdings to 2,576,845.

On March 8, 2026, he exercised 327,801 RSUs into the same number of common shares. To cover tax obligations, 128,918 common shares were withheld at $2.57 per share. After these transactions, he directly holds 12,809,295 common shares, plus his RSU awards.

Rhea-AI Summary

Cronos Group Inc. officer Buggy Shannon reported compensation-related stock activity involving restricted stock units and common shares. On March 9, 2026, Shannon received a grant of 48,638 RSUs, each representing one common share, vesting in three equal annual installments starting one year after the grant date.

On March 8, 2026, Shannon exercised RSUs covering 21,148 and 25,378 underlying common shares. To satisfy tax obligations, the company withheld 10,526 and 12,918 common shares at $2.57 per share. Following these transactions, Shannon directly held 142,941 common shares and 243,774 RSUs.

Rhea-AI Summary

Cronos Group Inc. officer Anna Shlimak reported several equity compensation transactions involving restricted stock units (RSUs) and common shares. On March 9, 2026, she received grants of 166,459 RSUs and 23,134 RSUs, each RSU representing one common share and vesting in three annual installments beginning on the first anniversary of the grant date.

On March 8, 2026, she exercised 45,680 RSUs into the same number of common shares, reflecting vesting from a prior grant dated March 8, 2024. Of those common shares, 18,943 were withheld at $2.57 per share to cover tax obligations, which is a non-market disposition. Following these transactions, she directly holds 280,923 common shares and 507,916 RSUs.

Rhea-AI Summary

Cronos Group Inc. reported insider equity transactions by Chairman, Chief Executive Officer and President Michael R. Gorenstein dated December 13, 2025. He acquired 166,642 common shares through the conversion of restricted stock units at a reported price of $0 and disposed of 65,002 common shares at $3.27 per share.

Following these transactions, he directly owns 12,610,412 common shares and holds 1,999,977 restricted stock units, each representing a contingent right to receive one Cronos common share. These units were originally granted on December 13, 2022 in an award of 499,826 restricted stock units vesting in three substantially equal annual installments beginning on the first anniversary of the grant date.

Rhea-AI Summary

Cronos Group Inc. executive Arye Weigensberg, Senior Vice President and Head of Research and Development, reported the vesting and settlement of 6,423 restricted stock units into common shares on 12/13/2025 at an exercise price of $0 per share.

After this transaction, he directly owns 135,892 Cronos Group common shares and continues to hold 153,918 restricted stock units, each representing a contingent right to receive one common share. These RSUs were originally granted on December 13, 2022 as part of a 19,266-unit award vesting in three substantially equal annual installments.

Rhea-AI Summary

Cronos Group Inc. (CRON) filed a Form 4 reporting an equity award to an executive. On November 7, 2025, the SVP, Head of Cronos Israel, received 60,728 restricted stock units (RSUs), each representing the right to receive one common share. The RSUs vest in three substantially equal annual installments beginning on the first anniversary of the grant date. Following this grant, 138,632 derivative securities were beneficially owned directly.